Clinics in Minnesota
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
What Minnesota law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.
Minnesota at a glance
- Pharmacy regulator
- Minnesota Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async unclear
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified clinics serving Minnesota
No verified clinics serving Minnesota are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Peptide access rules in Minnesota
Yes. A Minnesota resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Minnesota-licensed prescriber, including through telehealth. Minnesota Statutes section 151.37 requires a documented patient evaluation including an examination only for a listed set of drugs (controlled substances, muscle relaxants, opioid-type analgesics, butalbital products, and PDE5 inhibitors for erectile dysfunction), so GLP-1s and other peptides fall under the general standard of care instead. A compounded peptide is available when it is eligible under federal 503A rules and dispensed by a pharmacy licensed by the Minnesota Board of Pharmacy, and out-of-state pharmacies that regularly ship into Minnesota need a nonresident pharmacy license under section 151.19. [1] [2] [3] [4] [5] [6] [8] [9] [10] [11]
Compounded GLP-1 access in Minnesota
Minnesota's statutory examination requirement in section 151.37 does not list GLP-1s, so the main state-specific check for a telehealth GLP-1 program is licensure: a Minnesota-licensed prescriber and a pharmacy holding a Minnesota or nonresident Minnesota license. [2] [6] [12]
Research use only sellers in Minnesota
Minn. Stat. section 151.34 prohibits manufacturing, selling, or delivering adulterated or misbranded drugs and selling legend drugs without a prescription in Minnesota. [7] [13]
Minnesota notes on specific peptides
- Semaglutide: Available branded by prescription, including by telehealth; it is not one of the drugs for which Minn. Stat. section 151.37 requires a documented examination. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [2] [12]
How to check a clinic in Minnesota
- Confirm the prescribing clinician's license with the Minnesota medical or nursing board.
- Ask which pharmacy compounds or dispenses the peptide and check it in the Minnesota Board of Pharmacy license lookup. [1] [5] [6] [8] [9] [10] [11]
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Minnesota. [7] [13]
Common questions in Minnesota
Does Minnesota require an exam before a telehealth GLP-1 prescription?
Not by a specific statute. Minn. Stat. section 151.37 requires a documented examination only for listed drugs such as controlled substances, muscle relaxants, butalbital products, and PDE5 inhibitors for erectile dysfunction. GLP-1s are not on that list, so the prescriber decides what evaluation the standard of care requires. [2]
Can an out-of-state doctor treat me in Minnesota by telehealth?
Only if the doctor holds a Minnesota license or an interstate telehealth registration with the Minnesota Board of Medical Practice under Minn. Stat. section 147.032. [4]
Sources
- [1]Minnesota Board of Pharmacy
- [2]Minnesota Statutes section 151.37, Legend drugs; who may prescribe, possess
- [3]Minnesota Statutes section 62A.673, Coverage of services provided through telehealth (Minnesota Telehealth Act)
- [4]Minnesota Statutes section 147.032, Interstate practice of telemedicine
- [5]Minnesota Statutes chapter 151, Pharmacy Practice and Wholesale Distribution Act
- [6]Minnesota Statutes section 151.19, Pharmacy licensure requirements (including nonresident pharmacies)
- [7]Minnesota Statutes section 151.34, Prohibited acts
- [8]Minnesota Rules chapter 6800, Pharmacy and pharmacists
- [9]Minnesota Board of Pharmacy: guidance documents
- [10]Minnesota Board of Pharmacy: compounding FAQs